{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:59:46Z","timestamp":1788886786096,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 24K12281"],"award-info":[{"award-number":["JP 24K12281"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-024-01151-1","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T06:23:53Z","timestamp":1732861433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Establishment of a novel benign meningioma cell line spontaneously immortalized under hypoxic conditions"],"prefix":"10.1007","volume":"38","author":[{"given":"Takaaki","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2857-0374","authenticated-orcid":false,"given":"Masahide","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Toyomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zaboronok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"1151_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad149","author":"QT Ostrom","year":"2023","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016\u20132020. Neuro Oncol. 2023. https:\/\/doi.org\/10.1093\/neuonc\/noad149.","journal-title":"Neuro Oncol"},{"key":"1151_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab200","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018. Neuro Oncol. 2021. https:\/\/doi.org\/10.1093\/neuonc\/noab200.","journal-title":"Neuro Oncol"},{"issue":"2","key":"1151_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11060-005-9076-y","volume":"78","author":"GS Baia","year":"2006","unstructured":"Baia GS, Slocum AL, Hyer JD, Misra A, Sehati N, VandenBerg SR, et al. A genetic strategy to overcome the senescence of primary meningioma cell cultures. J Neurooncol. 2006;78(2):113\u201321. https:\/\/doi.org\/10.1007\/s11060-005-9076-y.","journal-title":"J Neurooncol"},{"issue":"9","key":"1151_CR4","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/labinvest.3700307","volume":"85","author":"S Puttmann","year":"2005","unstructured":"Puttmann S, Senner V, Braune S, Hillmann B, Exeler R, Rickert CH, et al. Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Lab Invest. 2005;85(9):1163\u201371. https:\/\/doi.org\/10.1038\/labinvest.3700307.","journal-title":"Lab Invest"},{"issue":"4","key":"1151_CR5","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1227\/01.NEU.0000255397.00410.8F","volume":"60","author":"TG Cargioli","year":"2007","unstructured":"Cargioli TG, Ugur HC, Ramakrishna N, Chan J, Black PM, Carroll RS. Establishment of an in vivo meningioma model with human telomerase reverse transcriptase. Neurosurgery. 2007;60(4):750\u20139. https:\/\/doi.org\/10.1227\/01.NEU.0000255397.00410.8F.","journal-title":"Neurosurgery"},{"key":"1151_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv377","author":"F Sahm","year":"2016","unstructured":"Sahm F, Schrimpf D, Olar A, Koelsche C, Reuss D, Bissel J, et al. TERT promoter mutations and risk of recurrence in meningioma. J Natl Cancer Inst. 2016. https:\/\/doi.org\/10.1093\/jnci\/djv377.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1151_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1530\/ERC-13-0210","volume":"20","author":"X Liu","year":"2013","unstructured":"Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, et al. Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer. 2013;20(4):603\u201310. https:\/\/doi.org\/10.1530\/ERC-13-0210.","journal-title":"Endocr Relat Cancer"},{"key":"1151_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6853","author":"M Allan","year":"2016","unstructured":"Allan M, Bjerke M, Edlund H, Nelander S, Westermark B. Origin of the U87MG glioma cell line: good news and bad news. Sci Transl Med. 2016. https:\/\/doi.org\/10.1126\/scitranslmed.aaf6853.","journal-title":"Sci Transl Med"},{"issue":"3","key":"1151_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1227\/00006123-199009000-00008","volume":"27","author":"WH Lee","year":"1990","unstructured":"Lee WH. Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery. 1990;27(3):389\u201396.","journal-title":"Neurosurgery"},{"key":"1151_CR10","unstructured":"THE HUMAN PROTEIN ATLAS. https:\/\/www.proteinatlas.org\/. https:\/\/www.proteinatlas.org\/ENSG00000147889-CDKN2A\/cell+line and https:\/\/www.proteinatlas.org\/ENSG00000147883-CDKN2B\/cell+line. Accessed 4 Sept 2024."},{"key":"1151_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa002","author":"J Merisaari","year":"2020","unstructured":"Merisaari J, Denisova OV, Doroszko M, Le Joncour V, Johansson P, Leenders WPJ, et al. Monotherapy efficacy of blood-brain barrier permeable small molecule reactivators of protein phosphatase 2A in glioblastoma. Brain Commun. 2020. https:\/\/doi.org\/10.1093\/braincomms\/fcaa002.","journal-title":"Brain Commun"},{"key":"1151_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling PA-O, Brat DA-O, Cree IA, Figarella-Branger D, et al. The WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021. https:\/\/doi.org\/10.1093\/neuonc\/noab106.","journal-title":"Neuro Oncol"},{"issue":"12","key":"1151_CR13","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/neuonc\/noy104","volume":"20","author":"S Spiegl-Kreinecker","year":"2018","unstructured":"Spiegl-Kreinecker S, Lotsch D, Neumayer K, Kastler L, Gojo J, Pirker C, et al. TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma. Neuro Oncol. 2018;20(12):1584\u201393. https:\/\/doi.org\/10.1093\/neuonc\/noy104.","journal-title":"Neuro Oncol"},{"issue":"6122","key":"1151_CR14","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science. 2013;339(6122):957\u20139. https:\/\/doi.org\/10.1126\/science.1229259.","journal-title":"Science"},{"issue":"15","key":"1151_CR15","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1073\/pnas.1303607110","volume":"110","author":"PJ Killela","year":"2013","unstructured":"Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr, et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A. 2013;110(15):6021\u20136. https:\/\/doi.org\/10.1073\/pnas.1303607110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1151_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.surneu.2007.06.031","volume":"70","author":"BT Ragel","year":"2008","unstructured":"Ragel BT, Couldwell WT, Gillespie DL, Wendland MM, Whang K, Jensen RL. A comparison of the cell lines used in meningioma research. Surg Neurol. 2008;70(3):295\u2013307. https:\/\/doi.org\/10.1016\/j.surneu.2007.06.031.","journal-title":"Surg Neurol"},{"key":"1151_CR17","first-page":"2386","volume":"53","author":"SA Rempel","year":"1993","unstructured":"Rempel SA, Schwechheimer K, Davis RL, Cavenee WK, Rosenblum ML. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res. 1993;53:2386\u201392.","journal-title":"Cancer Res"},{"issue":"4","key":"1151_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00401-003-0736-8","volume":"106","author":"K Akat","year":"2003","unstructured":"Akat K, Mennel HD, Kremer P, Gassler N, Bleck CK, Kartenbeck J. Molecular characterization of desmosomes in meningiomas and arachnoidal tissue. Acta Neuropathol. 2003;106(4):337\u201347. https:\/\/doi.org\/10.1007\/s00401-003-0736-8.","journal-title":"Acta Neuropathol"},{"key":"1151_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12935-020-01438-x","volume":"20","author":"E Kim","year":"2020","unstructured":"Kim E, Kim M, So K, Park YS, Woo CG, Hyun SH. Characterization and comparison of genomic profiles between primary cancer cell lines and parent atypical meningioma tumors. Cancer Cell Int. 2020;20:345. https:\/\/doi.org\/10.1186\/s12935-020-01438-x.","journal-title":"Cancer Cell Int"},{"key":"1151_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12967-015-0596-8","volume":"13","author":"SK Michelhaugh","year":"2015","unstructured":"Michelhaugh SK, Guastella AR, Varadarajan K, Klinger NV, Parajuli P, Ahmad A, et al. Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1. J Transl Med. 2015;13:227. https:\/\/doi.org\/10.1186\/s12967-015-0596-8.","journal-title":"J Transl Med"},{"issue":"3","key":"1151_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","volume":"140","author":"P Sievers","year":"2020","unstructured":"Sievers P, Hielscher T, Schrimpf D, Stichel D, Reuss DE, Berghoff AS, et al. CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol. 2020;140(3):409\u201313. https:\/\/doi.org\/10.1007\/s00401-020-02188-w.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1151_CR22","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1582-4934.2011.01258.x","volume":"15","author":"A Carreau","year":"2011","unstructured":"Carreau A, El Hafny-Rahbi B, Matejuk A, Grillon C, Kieda C. Why is the partial oxygen pressure of human tissues a crucial parameter? small molecules and hypoxia. J Cell Mol Med. 2011;15(6):1239\u201353. https:\/\/doi.org\/10.1111\/j.1582-4934.2011.01258.x.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"1151_CR23","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/00000539-199808000-00045","volume":"82","author":"M Miiller","year":"1998","unstructured":"Miiller M, Padberg W, Schindler E, Sticher J, Osmer C, Friemann S, et al. Renocortical tissue oxygen pressure measurements in patients undergoing living donor kidney transplantation. Anesth Analg. 1998;82(8):474\u20136. https:\/\/doi.org\/10.1097\/00000539-199808000-00045.","journal-title":"Anesth Analg"},{"key":"1151_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1023\/a:1015832726054","volume":"58","author":"T Beppu","year":"2002","unstructured":"Beppu T, Kamada K, Yoshida Y, Arai H, Ogasawara K. Chenge of oxygen pressure in GBM tissue under various conditions. J Neurooncol. 2002;58:47\u201352. https:\/\/doi.org\/10.1023\/a:1015832726054.","journal-title":"J Neurooncol"},{"key":"1151_CR25","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ncb1024","volume":"5","author":"S Parrinello","year":"2003","unstructured":"Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, Campisi J. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol. 2003;5:741\u20137. https:\/\/doi.org\/10.1038\/ncb1024.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"1151_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10522-007-9113-7","volume":"9","author":"DH Betts","year":"2008","unstructured":"Betts DH, Perrault SD, King WA. Low oxygen delays fibroblast senescence despite shorter telomeres. Biogerontology. 2008;9(1):19\u201331. https:\/\/doi.org\/10.1007\/s10522-007-9113-7.","journal-title":"Biogerontology"},{"key":"1151_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1196\/annals.1404.025","volume":"1119","author":"E Poulios","year":"2007","unstructured":"Poulios E, Trougakos IP, Chondrogianni N, Gonos ES. Exposure of human diploid fibroblasts to hypoxia extends proliferative life span. Ann N Y Acad Sci. 2007;1119:9\u201319. https:\/\/doi.org\/10.1196\/annals.1404.025.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1151_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13046-021-02035-0","volume":"40","author":"D Otero-Albiol","year":"2021","unstructured":"Otero-Albiol D, Carnero A. Cellular senescence or stemness: hypoxia flips the coin. J Exp Clin Cancer Res. 2021;40(1):243. https:\/\/doi.org\/10.1186\/s13046-021-02035-0.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"1151_CR29","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1172\/JCI95148","volume":"128","author":"N Herranz","year":"2018","unstructured":"Herranz N, Gil J. Mechanisms and functions of cellular senescence. J Clin Invest. 2018;128(4):1238\u201346. https:\/\/doi.org\/10.1172\/JCI95148.","journal-title":"J Clin Invest"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-024-01151-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T08:26:19Z","timestamp":1736411179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-024-01151-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["1151"],"URL":"https:\/\/doi.org\/10.1007\/s13577-024-01151-1","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no financial or other conflict of interest to this research and its publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was approved by the Ethical Review Committee of the University of Tsukuba Hospital (Approval No. H29-314). The patient provided informed consent and a written agreement to participate in this study. The animal experiment was approved by the University of Tsukuba Animal Experiment Ethics Committee (Approval No. 23\u2013058). All animal experiments were conducted in accordance with the animal experimentation regulations of the University of Tsukuba.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"22"}}